187 related articles for article (PubMed ID: 37264016)
1. The blood proteome of imminent lung cancer diagnosis.
Lung Cancer Cohort Consortium (LC3)
Nat Commun; 2023 Jun; 14(1):3042. PubMed ID: 37264016
[TBL] [Abstract][Full Text] [Related]
2. Circulating inflammation markers and prospective risk for lung cancer.
Shiels MS; Pfeiffer RM; Hildesheim A; Engels EA; Kemp TJ; Park JH; Katki HA; Koshiol J; Shelton G; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2013 Dec; 105(24):1871-80. PubMed ID: 24249745
[TBL] [Abstract][Full Text] [Related]
3. Associations of Insulin and IGFBP-3 with Lung Cancer Susceptibility in Current Smokers.
Ho GYF; Zheng SL; Cushman M; Perez-Soler R; Kim M; Xue X; Wang T; Schlecht NF; Tinker L; Rohan TE; Wassertheil-Smoller S; Wallace R; Chen C; Xu J; Yu H
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 27071409
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis.
Yu H; Spitz MR; Mistry J; Gu J; Hong WK; Wu X
J Natl Cancer Inst; 1999 Jan; 91(2):151-6. PubMed ID: 9923856
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor I, IGF-binding protein 3, and lung cancer risk in a prospective study of men in China.
London SJ; Yuan JM; Travlos GS; Gao YT; Wilson RE; Ross RK; Yu MC
J Natl Cancer Inst; 2002 May; 94(10):749-54. PubMed ID: 12011225
[TBL] [Abstract][Full Text] [Related]
7. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
Spitz MR; Barnett MJ; Goodman GE; Thornquist MD; Wu X; Pollak M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
[TBL] [Abstract][Full Text] [Related]
8. Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.
Douglas JB; Silverman DT; Pollak MN; Tao Y; Soliman AS; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2298-306. PubMed ID: 20699371
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of immune and inflammation markers and risk of lung cancer among female never smokers in Shanghai.
Shiels MS; Shu XO; Chaturvedi AK; Gao YT; Xiang YB; Cai Q; Hu W; Shelton G; Ji BT; Pinto LA; Kemp TJ; Rothman N; Zheng W; Hildesheim A; Lan Q
Carcinogenesis; 2017 Oct; 38(10):1004-1010. PubMed ID: 28981818
[TBL] [Abstract][Full Text] [Related]
10. Circulating Inflammation Markers, Risk of Lung Cancer, and Utility for Risk Stratification.
Shiels MS; Katki HA; Hildesheim A; Pfeiffer RM; Engels EA; Williams M; Kemp TJ; Caporaso NE; Pinto LA; Chaturvedi AK
J Natl Cancer Inst; 2015 Oct; 107(10):. PubMed ID: 26220734
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against insulin-like growth factor‑binding protein-2 as a serological biomarker in the diagnosis of lung cancer.
Zhang Y; Ying X; Han S; Wang J; Zhou X; Bai E; Zhang J; Zhu Q
Int J Oncol; 2013 Jan; 42(1):93-100. PubMed ID: 23165420
[TBL] [Abstract][Full Text] [Related]
12. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
[TBL] [Abstract][Full Text] [Related]
13. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
14. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
[TBL] [Abstract][Full Text] [Related]
15. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis.
Cao H; Wang G; Meng L; Shen H; Feng Z; Liu Q; Du J
PLoS One; 2012; 7(11):e49884. PubMed ID: 23185474
[TBL] [Abstract][Full Text] [Related]
16. Plasma protein biomarkers for early prediction of lung cancer.
Davies MPA; Sato T; Ashoor H; Hou L; Liloglou T; Yang R; Field JK
EBioMedicine; 2023 Jul; 93():104686. PubMed ID: 37379654
[TBL] [Abstract][Full Text] [Related]
17. Serum insulin-like growth factors, insulin-like growth factor-binding protein-3, and risk of lung cancer death: a case-control study nested in the Japan Collaborative Cohort (JACC) Study.
Wakai K; Ito Y; Suzuki K; Tamakoshi A; Seki N; Ando M; Ozasa K; Watanabe Y; Kondo T; Nishino Y; Ohno Y;
Jpn J Cancer Res; 2002 Dec; 93(12):1279-86. PubMed ID: 12495466
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Cytokines and Lung Cancer Risk in 3 Prospective Studies.
Brenner DR; Fanidi A; Grankvist K; Muller DC; Brennan P; Manjer J; Byrnes G; Hodge A; Severi G; Giles GG; Johansson M; Johansson M
Am J Epidemiol; 2017 Jan; 185(2):86-95. PubMed ID: 27998891
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Wei EK; Ma J; Pollak MN; Rifai N; Fuchs CS; Hankinson SE; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):850-5. PubMed ID: 15824155
[TBL] [Abstract][Full Text] [Related]
20. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]